Trial Profile
Study of Dexmedetomidine as an Effective Sedative to Treat Acute ICU Delirium
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Jun 2017
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary)
- Indications Delirium
- Focus Therapeutic Use
- 29 Mar 2017 Status changed from active, no longer recruiting to completed.
- 11 May 2010 Planned number of patients (130) added as reported by ClinicalTrials.gov record.
- 11 May 2010 Planned end date (1 Sep 2011) added as reported by ClinicalTrials.gov record.